Nicscreen-constituent nicotine receptor phase II and III-follow on to contract HHSF223201310070C

Ended Definitive Contract Awarded Last action

Contract number
HHSF223201510026C
Awardee
Awarding agency
Obligated
$1,700,899

Award facts

Contract value 100% obligated
$1,700,899.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 4 · Modification to extend the period of performance until 11/30/2018 for contract HHSF223201510026C $0
Other Administrative Action 3 · Modification to extend the period of performance until 11/30/2017 for contract HHSF223201510026C $0
Other Administrative Action 2 · Modification to change the contracting officer representative (COR)for contract HHSF223201510026C $0
Other Administrative Action 1 · Modification to delete contract clasues that are not appicable to the contract HHSF223201510026C $0
Original award $1,700,899

About this award

Written by GovTribe AI ·

This is a Definitive Contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Charles River Laboratories Cleveland, Inc. The contract has a Firm Fixed Price pricing type and a ceiling value of $1,700,899.00. The contract is for the "NICSCREEN-CONSTITUENT NICOTINE RECEPTOR PHASE II AND III" research project, which is a follow-on to a previous contract. The contract does not have a set-aside designation and is scheduled for completion by November 30, 2018. Charles River Laboratories Cleveland, Inc. is a for-profit organization that specializes in providing laboratory services and products related to ion channel studies and nicotine receptor research, primarily for the CDC within HHS.

Quick answers

Who was awarded contract HHSF223201510026C?

HHSF223201510026C was awarded to Charles River Laboratories Cleveland, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 31, 2015.

How much is contract HHSF223201510026C worth?

The government has obligated $1,700,899 on HHSF223201510026C.

Was contract HHSF223201510026C competed?

The extent of competition for HHSF223201510026C was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login